-
In contrast to arterial thrombo-embolic ischemic stroke, cerebral venous sinus thrombosis (CVST) is unique in its clinical presentation and treatment algorithm. As reported by Ferro and associates on behalf of the multicenter international ISCVT study, venous stroke, typically treated with heparin, has a good outcome in the vast majority of cases.
-
The U.S. Food and Drug Administration has announced a qualified health claim for reduced risk of coronary heart disease on conventional foods that contain the omega-3 fatty acids eiscosapentaenoic acid and docosahexaenoic acid.
-
Recent studies in intensive care units1 (ICU) have found that critical care specialists often try to base decisions about withdrawal of advanced life support measures based on their perception of the patients wishes and the likelihood of survival in the ICU. But making accurate decisions about a patients wishes in such situations often requires clinicians to communicate effectively with surrogate decision makers members of the patients family or others empowered to make decisions should the person become incapacitated.
-
Many adults do not understand health information. Nearly half of all American adults 90 million have difficulty understanding and using health information, and there is a higher rate of hospitalization and use of emergency services among patients with such limited health literacy, states a new report from the Institute of Medicine (IOM).
-
-
At the 16th annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington in late September, companies big and small presented compelling data from various studies for new products that they hope will lead to newly approved products in the interventional cardiology sector as well as showcased recently cleared devices that could potentially revolutionize the medical field.
-
Edwards Lifesciences (Irvine, California) reported that it has enhanced its core heart valve business with the acquisition of all technology and intellectual property associated with ev3s (Plymouth, Minnesota) percutaneous mitral valve repair program for roughly $15 million.
-
Dade Behring (Deerfield, Illinois), the University of Frankfurt (Frankfurt, Germany) and Innovectis (also Frankfurt) have signed an exclusive license agreement that provides Dade Behring with worldwide rights for the inventions of a research group at the university that relate to placental growth factor (PlGF) for cardiovascular diseases, soluble CD40 ligand for the prognosis of the course of disease in acute coronary syndrome (ACS), and additional markers for cardiovascular diseases.
-
Access managers could benefit by stretching a bit beyond their boundaries and actively seeking participation in the clinical side of health care, suggests Karen McKinley, RN, CHAM, vice president of patient access and care management for Geisinger Health System in Danville, PA.
-
Thirty-six million Americans do not have access to basic health care because they live in communities with an acute shortage of health care providers.
